A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease

Classical non-insulin antihyperglycemic drugs currently approved for the treatment of type 2 diabetes mellitus (T2DM) comprise five groups: biguanides, sulfonylureas, meglitinides, glitazones and alpha-glucosidase inhibitors. Novel compounds are represented by the incretin mimetic drugs like glucago...

Descripción completa

Detalles Bibliográficos
Autores principales: Fisman, Enrique Z, Tenenbaum, Alexander
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723076/
https://www.ncbi.nlm.nih.gov/pubmed/19619327
http://dx.doi.org/10.1186/1475-2840-8-38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723076/
https://www.ncbi.nlm.nih.gov/pubmed/19619327
http://dx.doi.org/10.1186/1475-2840-8-38

Ejemplares similares